EXACT Sciences Corp. (EXAS)

109.10
5.10 4.90
NASDAQ : Health Technology
Prev Close 103.97
Open 109.94
Day Low/High 107.66 / 113.10
52 Wk Low/High 53.06 / 123.99
Volume 1.00M
Avg Volume 1.53M
Exchange NASDAQ
Shares Outstanding 129.49M
Market Cap 13.39B
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)
Exact Sciences Highlights CMS Advisory Panel's Unanimous Vote To Maintain Medicare Reimbursement Rate For Cologuard®

Exact Sciences Highlights CMS Advisory Panel's Unanimous Vote To Maintain Medicare Reimbursement Rate For Cologuard®

Exact Sciences Corp. (NASDAQ: EXAS) today announced that the Centers for Medicare and Medicaid Services (CMS) Advisory Panel on Clinical Diagnostic Laboratory Tests voted unanimously to maintain Medicare's current crosswalk...

Exact Sciences Wins Wisconsin Innovation Award

Exact Sciences Wins Wisconsin Innovation Award

Exact Sciences Corp. (NASDAQ: EXAS) today announced that Cologuard was awarded a Wisconsin Innovation Award (WIA) in the "Healthcare/Health IT" category at the second annual ceremony held on August 18, 2015 at...

EXACT Sciences Stock Sees Short Interest Drop 14.3%

EXACT Sciences Stock Sees Short Interest Drop 14.3%

The most recent short interest data has been released by the NASDAQ for the 07/31/2015 settlement date, which shows a 3,864,520 share decrease in total short interest for EXACT Sciences Corp. , to 23,105,130, a decrease of 14.33% since 07/15/2015.

Exact Sciences To Participate In August Conferences

Exact Sciences To Participate In August Conferences

Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will participate in two investor conferences during August.

Exact Sciences Could 'Take Off' if Key Product Rates Highly, Says Manager

Exact Sciences Could 'Take Off' if Key Product Rates Highly, Says Manager

Although shares of Exact Sciences have fallen 18% over the past month, its cancer screening product Cologuard is already in use at the Mayo Clinic.

Canadian, Trina Solar Will Bounce Back Says Green Alpha Manager

Canadian, Trina Solar Will Bounce Back Says Green Alpha Manager

Exact Sciences (EXAS) shares have pulled back in the past month due to a secondary offering and profit taking after a huge run-up.

'Mad Money' Lightning Round: I Like Kroger, It's Today's Domestic Stock

'Mad Money' Lightning Round: I Like Kroger, It's Today's Domestic Stock

Cramer says the problem with General Electric is that it's doing nothing.

In praise of soft activism

In praise of soft activism

Original and detailed research can accelerate price discovery.

Jim Cramer's 'Mad Money' Recap: Road to China Is Lined With Bears and Bulls

Jim Cramer's 'Mad Money' Recap: Road to China Is Lined With Bears and Bulls

Cramer is not worried about Apple, and suggests viewers sit back and wait until the post-earnings panic subsides.

Exact (EXAS) Stock: Weak On High Volume Today

Exact (EXAS) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Exact (EXAS) as a weak on high relative volume candidate

Exact Sciences (EXAS) Stock Falls on Public Offering Pricing

Exact Sciences (EXAS) Stock Falls on Public Offering Pricing

Exact Sciences (EXAS) shares are lower following the pricing of the company's 7 million share public offering.

Exact Sciences Announces Pricing Of Public Offering Of Common Stock

Exact Sciences Announces Pricing Of Public Offering Of Common Stock

Exact Sciences Corporation (NASDAQ: EXAS) today announced that Jefferies LLC and Robert W.

Exact Sciences Announces Agreement To Sell 7,000,000 Common Shares

Exact Sciences Announces Agreement To Sell 7,000,000 Common Shares

Exact Sciences Corporation (NASDAQ: EXAS) today announced an agreement to sell 7,000,000 shares of its common stock to Jefferies LLC and Robert W.

Exact Sciences Highlights Cologuard's® Positive Launch Trajectory In Second Quarter 2015

Exact Sciences Highlights Cologuard's® Positive Launch Trajectory In Second Quarter 2015

Exact Sciences Corp. (Nasdaq: EXAS) today announced its business and financial results for the second quarter of 2015, and showed continued strong performance with more than 21,000 completed Cologuard tests for the quarter,...

Exact Sciences to Host Second-Quarter 2015 Results, Annual Meeting Webcasts and Calls

Exact Sciences to Host Second-Quarter 2015 Results, Annual Meeting Webcasts and Calls

Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host webcasts and conference calls to discuss its second-quarter 2015 financial results and of its annual stockholders meeting.

'Fast Money' Recap: Stay Away From Semiconductor Stocks

'Fast Money' Recap: Stay Away From Semiconductor Stocks

The trading panel discussed Micron's awful earnings, which Chinese stocks to buy and whether eBay will do better or worse after it spins off PayPal.

Exact Sciences (EXAS) Stock Earnings Estimates Raised at Canaccord

Exact Sciences (EXAS) Stock Earnings Estimates Raised at Canaccord

Shares of Exact Sciences (EXAS) are gaining after Canaccord raised its 2015 earnings estimates to $1.63 from $1.55, with 2016 earnings estimates increased to $1.09 from $0.99.

Fly Watch: Exact Sciences Predicted To Jump If Task Force Update Favorable

Fly Watch: Exact Sciences Predicted To Jump If Task Force Update Favorable

The US Preventive Services Task Force, or USPSTF, is expected to publish its revised guidelines for colorectal cancer, or CRC, screening in the third quarter of 2015.

Today's Water-Logged And Getting Wetter Stock: Exact (EXAS)

Today's Water-Logged And Getting Wetter Stock: Exact (EXAS)

Trade-Ideas LLC identified Exact (EXAS) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Exact Sciences Provides Update On Strong Launch Trajectory Of Cologuard®

Exact Sciences Provides Update On Strong Launch Trajectory Of Cologuard®

Exact Sciences Corp. (Nasdaq: EXAS) today announced that it expects to end the second quarter of 2015 with approximately 21,000 completed Cologuard tests.

Exact (EXAS) Hits New Lifetime High

Exact (EXAS) Hits New Lifetime High

Trade-Ideas LLC identified Exact (EXAS) as a new lifetime high candidate

Exact Sciences (EXAS) Stock Gains After Price Target Increase at Canaccord

Exact Sciences (EXAS) Stock Gains After Price Target Increase at Canaccord

Shares of Exact Sciences (EXAS) are climbing after Canaccord raised its price target to $32 from $30, while maintaining its 'buy' rating.

Exact Sciences To Webcast Investor & Analyst Day

Exact Sciences To Webcast Investor & Analyst Day

Exact Sciences Corp. (Nasdaq: EXAS) today announced that it will provide a live video webcast and conference call for its Investor & Analyst Day on June 25.

Exact (EXAS) Stock: Weak On High Volume Today

Exact (EXAS) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Exact (EXAS) as a weak on high relative volume candidate

'Mad Money' Lightning Round: Buy Taser, Have Patience With Baxter

'Mad Money' Lightning Round: Buy Taser, Have Patience With Baxter

Cramer thinks Gigamon stays hot and hasn't backed away from Biogen Idec.

Jim Cramer's 'Mad Money' Recap: 3 Things Frightening the Market Right Now

Jim Cramer's 'Mad Money' Recap: 3 Things Frightening the Market Right Now

The May job number is just the start of what could be another tough day, Cramer warns.

Exact Sciences And MD Anderson Cancer Center Announce Partnership To Develop Screening And Diagnostic Tests For Lung Cancer

Exact Sciences And MD Anderson Cancer Center Announce Partnership To Develop Screening And Diagnostic Tests For Lung Cancer

Exact Sciences Corp. (NASDAQ: EXAS) and The University of Texas MD Anderson Cancer Center today announced an agreement to jointly develop and commercialize blood-based screening and diagnostic tests for the early...

'Fast Money' Recap: Raging Nasdaq, Stripped Down Kors, Small Appetite for McDonald's

'Fast Money' Recap: Raging Nasdaq, Stripped Down Kors, Small Appetite for McDonald's

The Fast Money panel saw opportunities in the white-hot semiconductor industry and also considered the struggling casino industry -- in Macau and abroad.

Exact Sciences To Participate In June Investor Conferences

Exact Sciences To Participate In June Investor Conferences

Exact Sciences Corp. (Nasdaq: EXAS) today announced that it will participate in three investor conferences during June to highlight the company's commercial strategy that's driving the strong early growth of Cologuard.

Exact (EXAS) Marked As A Dead Cat Bounce Stock

Exact (EXAS) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Exact (EXAS) as a "dead cat bounce" (down big yesterday but up big today) candidate

TheStreet Quant Rating: C- (Hold)